ロード中...
Targeting survival pathways in chronic myeloid leukaemia stem cells
Chronic myeloid leukaemia (CML) is a clonal myeloproliferative disorder characterized by the presence of a fusion oncogene BCR-ABL, which encodes a protein with constitutive TK activity. The implementation of tyrosine kinase inhibitors (TKIs) marked a major advance in CML therapy; however, there are...
保存先:
| 主要な著者: | , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Blackwell Publishing Ltd
2013
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3753830/ https://ncbi.nlm.nih.gov/pubmed/23517124 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bph.12183 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|